Editors’ Picks
Research Highlights
Predictors of Cancer Risk in the Long-Term Solid-Organ Transplant Recipient
Antithymocyte Globulin Is Associated With a Lower Incidence of De Novo Donor-Specific Antibodies in Moderately Sensitized Renal Transplant Recipients
Graft Reconditioning With Nitric Oxide Gas in Rat Liver Transplantation From Cardiac Death Donors
Knockdown of MicroRNA-155 in Kupffer Cells Results in Immunosuppressive Effects and Prolongs Survival of Mouse Liver Allografts
Long-Term Follow-Up of a Phase III Clinical Trial Comparing Tacrolimus Extended-Release/MMF, Tacrolimus/MMF, and Cyclosporine/MMF in De Novo Kidney Transplant Recipients
Preformed Donor-Specific Antibodies and Risk of Antibody-Mediated Rejection in Repeat Renal Transplantation
Fever, Infection, and Rejection After Kidney Transplant Failure
Management of Renal Masses in Transplant Allografts at an Australian Kidney-Pancreas Transplant Unit
Association of Interferon Gamma Gene Polymorphisms With BK Virus Infection Among Hispanic Renal Allograft Recipients
Pulsatile Perfusion Reduces the Risk of Delayed Graft Function in Deceased Donor Kidney Transplants, Irrespective of Donor Type and Cold Ischemic Time
Kidney Function Before Pancreas Transplant Alone Predicts Subsequent Risk of End-Stage Renal Disease
Clinical Outcomes Associated With the Early Postoperative Use of Heparin in Pancreas Transplantation
Effects of Cardiovascular Comorbidity Adjustment on SRTR Risk-Adjusted Cox Proportional Hazard Models of Graft Survival
Peritransplant Lymphopenia Is a Novel Prognostic Factor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation
Best Single Time Point Correlations With AUC for Cyclosporine and Tacrolimus in HIV-Infected Kidney and Liver Transplant Recipients
Utility of Gene Expression Profiling Score Variability to Predict Clinical Events in Heart Transplant Recipients
Is Absolute Lymphocyte Count a Good Prognostic Predictor in Recurrence of Hepatocellular Carcinoma After Liver Transplantation?
The Authors’ Reply
Liver Transplantation for Liver Malignancies in Wilson’s Disease
Donor-derived Mesenchymal Stem Cells Combined with Low-dose Tacrolimus Prevent Acute Rejection After Renal Transplantation
The OSAKA Trial